CHOP: Clinical Trials

6 trials of CHOP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6

Follow CHOP: new trials by email Literature Review of CHOP trials Research Report on CHOP

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients
Obinutuzumab, Ibrutinib, CHOP - Richter Syndrome
Phase 2TerminatedNorthwell Health32017-06-192023-06-01
Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.
Obinutuzumab, Ibrutinib, CHOP - Lymphoma, B-Cell
Phase 2TerminatedFondazione Italiana Linfomi - ETS12016-09-012017-03-20
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
CHOP + CD4, CHOP - T-cell Lymphoma
Phase 2TerminatedEmergent BioSolutions52007-05-012026-10-07
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
GM-CSF, CHOP, Rituximab - Lymphoma, Non-Hodgkin, Lymphoma, B-Cell
Phase 2TerminatedMassachusetts General Hospital32006-12-012018-01-18
Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)
Rituximab, CHOP - Post-transplantation Lymphoproliferative Disorder
Phase 2TerminatedCharite University, Berlin, Germany702002-12-012011-10-25
Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma
rituximab, CHOP - AIDS Related Lymphoma
Phase 2TerminatedFrench National Agency for Research on AIDS and Viral Hepatitis601999-01-012005-08-17

Conditions studied

Lymphoma, B-Cell (2)  ·  Leukemia (1)  ·  Lymphoma, AIDS-Related (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Emergent BioSolutions (1)  ·  Fondazione Italiana Linfomi - ETS (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Massachusetts General Hospital (1)  ·  Northwell Health (1)

Countries

France (2)  ·  United States (2)  ·  Australia (1)  ·  Germany (1)  ·  Italy (1)  ·  Sweden (1)

Top investigators

Dominique Costagliola (1)  ·  Ephraim P Hochberg, MD (1)  ·  Francois Boue, MD (1)  ·  Jacqueline Barrientos, MD (1)  ·  Maurizio Martelli, MD (1)  ·  Ralf U Trappe, MD (1)

Results publications

PMID 22173060, PMID 27992268

NIH funding

2015 (1)